Excedrin Extra Strength OTC migraine use efficacy, safety shown, FDA cmte. agrees.
This article was originally published in The Tan Sheet
Executive Summary
EXCEDRIN EXTRA STRENGTH OTC MIGRAINE USE EFFICACY, SAFETY SHOWN by Bristol-Myers Squibb data, members of three FDA advisory committees agreed at a July 15 joint meeting in Bethesda, Md. The agency's Nonprescription Drugs and Arthritis Advisory Committees and members of the Peripheral & Central Nervous System Drugs Advisory Committee voted unanimously that the company provided adequate evidence to support the effectiveness of Excedrin Extra Strength for OTC use in migraine.